Oppenheimer & Co Inc’s Pfizer Inc Position
Does Oppenheimer & Co Inc own Pfizer Inc (PFE)? Yes — 831.6K shares worth $23M (+0.28% of its 13F portfolio) as of Q1 2026, up from 694.6K shares the prior filed quarter.
Position Value
$23M
Q1 2026
Shares
831.6K
% of Portfolio
+0.28%
Quarters Held
30
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 831.6K | $23M | +0.28% |
| Q4 2025 | 694.6K | $17M | +0.25% |
| Q3 2025 | 703.4K | $18M | +0.22% |
| Q2 2025 | 641.6K | $16M | +0.21% |
| Q1 2025 | 636.2K | $16M | +0.24% |
| Q4 2024 | 581.4K | $15M | +0.23% |
| Q3 2024 | 658.4K | $19M | +0.29% |
| Q2 2024 | 604.9K | $17M | +0.27% |
| Q1 2024 | 607.4K | $17M | +0.28% |
| Q4 2023 | 511.2K | $15M | +0.27% |
| Q3 2023 | 649.5K | $22M | +0.44% |
| Q2 2023 | 700.8K | $26M | +0.51% |
| Q1 2023 | 684.0K | $28M | +0.59% |
| Q4 2022 | 653.2K | $33M | +0.76% |
| Q3 2022 | 668.8K | $29M | +0.68% |
| Q2 2022 | 706.8K | $37M | +0.80% |
| Q1 2022 | 746.7K | $39M | +0.70% |
| Q4 2021 | 730.0K | $43M | +0.75% |
| Q3 2021 | 677.5K | $29M | +0.55% |
| Q2 2021 | 674.8K | $26M | +0.47% |
| Q1 2021 | 654.6K | $24M | +0.47% |
| Q4 2020 | 663.9K | $24M | +0.52% |
| Q3 2020 | 643.1K | $24M | +0.59% |
| Q2 2020 | 685.9K | $22M | +0.58% |
| Q1 2020 | 805.4K | $26M | +0.80% |
| Q4 2019 | 770.3K | $30M | +0.75% |
| Q3 2019 | 755.4K | $27M | +0.74% |
| Q2 2019 | 761.8K | $33M | +0.90% |
| Q1 2019 | 790.2K | $34M | +0.90% |
| Q4 2018 | 767.9K | $34M | +1.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of PFE.